Florence Oberkampf

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia

P. Cony-Makhoul, S. de Botton, P. Rousselot, 2018, Leukemia & lymphoma.

Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration

M. Gutiérrez, G. Paintaud, C. Bonneau, 2021, Clinical pharmacology and therapeutics.

Response to "Intrathecal trastuzumab: What else do we need to consider?" by Gao et al.

C. Bonneau, É. Le Rhun, Florence Oberkampf, 2022, Neuro-oncology.

Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.

S. Vacher, S. Taillibert, O. Trédan, 2022, Neuro-oncology.